NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 6 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,000 | -33.3% | 12,500 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | +50.0% | 12,500 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | -33.3% | 12,500 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q1 2018 | $3,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | +50.0% | 12,500 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | -33.3% | 12,500 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | -25.0% | 12,500 | 0.0% | 0.00% | – |
| Q4 2016 | $4,000 | -42.9% | 12,500 | 0.0% | 0.00% | – |
| Q3 2016 | $7,000 | 0.0% | 12,500 | 0.0% | 0.00% | – |
| Q2 2016 | $7,000 | -61.1% | 12,500 | 0.0% | 0.00% | – |
| Q1 2016 | $18,000 | -55.0% | 12,500 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $40,000 | – | 12,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 24,815,028 | $8,638,000 | 0.42% |
| HYMAN CHARLES D | 249,625 | $87,000 | 0.01% |
| Montecito Bank & Trust | 75,717 | $26,000 | 0.01% |
| WEDBUSH SECURITIES INC | 127,200 | $44,000 | 0.01% |
| BIEGEL & WALLER LLC | 11,500 | $5,000 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 31,660 | $11,000 | 0.00% |
| MAIRS & POWER INC | 12,500 | $4,000 | 0.00% |
| BRANDES INVESTMENT PARTNERS, LP | 65,000 | $23,000 | 0.00% |